StockNews.com Begins Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research note released on Tuesday. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

AMPE opened at $0.00 on Tuesday. The firm has a market cap of $2,497.00, a PE ratio of 0.00 and a beta of 3.67. Ampio Pharmaceuticals has a 12-month low of $0.00 and a 12-month high of $7.47.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.